One week of esomeprazole triple therapy vs. 1 week of omeprazole triple therapy plus 3 weeks of omeprazole for duodenal ulcer healding in Helicobacter pylori-positive patients

Digestive Diseases and Sciences

Volumn 52, Issue 6, 2007, Pages 1505-1512

  Subei, Iyad M ^a   Cardona, Hector José ^b   Bachelet, Ernesto ^c   Useche, Emerson ^d   Arigbabu, Anthony ^e   Hammour, Adnan Abu ^f   Miller, Tom ^g  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b Internal Medicine Gastroenterology and Epidemiology   (Colombia)

^c Hospital Dr Gustavo Fricke   (Chile)

^d Clinica Razetti de Barquisimeto   (Venezuela)

^e OAU   (Nigeria)

^f Dubai Healthcare City   (United Arab Emirates)

^g ASTRAZENECA   (United Kingdom)

Author keywords

Duodenal ulcer; Esomeprazole; Helicobacter pylori; Omeprazole; Triple therapy

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; ESOMEPRAZOLE; OMEPRAZOLE; PLACEBO;

ABDOMINAL PAIN; ADULT; ARTICLE; ASTHENIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DUODENUM; DUODENUM ULCER; DYSGEUSIA; FEMALE; HEART PALPITATION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; NAUSEA; PRIORITY JOURNAL; PTOSIS; RANDOMIZED CONTROLLED TRIAL; RESTLESSNESS; TREATMENT DURATION; TREATMENT OUTCOME; VOMITING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-ULCER AGENTS; DOUBLE-BLIND METHOD; DUODENAL ULCER; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE;

EID: 34248672269     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-9522-5     Document Type: Article

References (20)

1. Huang JQ, Sridhar S, Hunt RH (2002) Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet 359:14-22
2. Tytgat GNJ, Lee A, Graham DY, Dixon MF, Rokkas T (1993) The role of infectious agents in peptic ulcer disease. Gastroenterol Int 6:76-89
3. Lam SK, Ching CK, Lai KC, Wong BC, Lai CL, Chan CK, Ong L (1997) Does treatment of Helicobacter pylori with antibiotics alone heal duodenal ulcer? A randomised double blind placebo controlled study. Gut 41:43-48
4. Malfertheiner P, Megraud F, O'Morain C, Hungin AP, Jones R, Axon A, Graham DY, Tytgat G, European Helicobacter Pylori Study Group (EHPSG) (2002) Current concepts in the management of Helicobacter pylori infection-the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 16(2):167-180
5. Howden CW, Hunt RH (1998) Guidelines for the management of Helicobacter pylori infection. Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology. Am J Gastroenterol 93(12):2330-2338
6. International Agency for Research on Cancer (IARC) (1994) Schistosomes, liver flukes and Helicobacter pylori. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol 61. IARC Press, Lyon, France, p 177
7. Lind T, Veldhuyzen van Zanten S, Unge P, Spiller R, Bayerdorffer E, O'Morain C, Bardhan KD, Bradette M, Chiba N, Wrangstadh M, Cederberg C, Idstrom JP (1996) Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH 1 study. Helicobacter 1:138-144
8. Lind T, Bardhan KD, Bayerdörffer E et al (1999) The MACH 2 study: optimal Helicobacter pylori therapy needs omeprazole and can be reliably assessed by UBT. Gastroenterol 112(Suppl 4):A200
9. Unge P (1999) The OAC and OMC options. Eur J Gastroenterol Hepatol 11(Suppl 2):S9-S17
10. Labenz J, Idstrom JP, Tillenburg B, Peitz U, Adamek RJ, Borsch G (1997) One-week low-dose triple therapy for Helicobacter pylori is sufficient for relief from symptoms and healing of duodenal ulcers. Aliment Pharmacol Ther 11(1):89-93
11. Lind T, Rydberg L, Kyleback A, Jonsson A, Andersson T, Hasselgren G, Holmberg J, Rohss K (2000) Esomeprazole provides improved acid control vs. omeprazole in patients with symptoms of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 14(7):861-867
12. Miner Jr P, Katz PO, Chen Y, Sostek M (2003) Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study. Am J Gastroenterol 98(12):2616-2620
13. Rohss K, Lind T, Wilder-Smith C (2004) Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms. Eur J Clin Pharm 60(8):531-539
14. Kahrilas PJ, Falk GW, Johnson DA, Schmitt C, Collins DW, Whipple J, D'Amico D, Hamelin B, Joelsson B (2000) Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial. Aliment Pharmacol Ther 14(10):1249-1258
15. Richter JE, Kahrilas PJ, Johanson J, Maton P, Breiter JR, Hwang C, Marino V, Hamelin B, Levine JG, Esomeprazole Study Investigators (2001) Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial. Am J Gastroenterol 96(3):656-665
16. Tulassay Z, Kryszewski A, Dite P, Kleczkowski D, Rudzinski J, Bartuzi Z, Hasselgren G, Larko A, Wrangstadh M (2001) One week of treatment with esomeprazole-based triple therapy eradicates Helicobacter pylori and heals patients with duodenal ulcer disease. Eur J Gastroenterol Hepatol 13(12):1457-1465
17. Windsor HM, Abioye-Kuteyi EA, Leber JM, Morrow SD, Bulsara MK, Marshall BJ (2005) Prevalence of Helicobacter pylori in Indigenous Western Australians: comparison between urban and remote rural populations. Med J Aust 182(5):210-213
18. Laine L, Fennerty MB, Osato M, Sugg J, Suchower L, Probst P, Levine JG (2000) Esomeprazole-based Helicobacter pylori eradication therapy and the effect of antibiotic resistance: results of three US multicenter, double-blind trials. Am J Gastroenterol 95(12):3393-3398
19. Gisbert JP, Pajares JM (2005) Systematic review and meta-analysis: Is 1-week proton pump inhibitor-based triple therapy sufficient to heal peptic ulcer? Aliment Pharmacol Ther 21:795-804
20. AstraZeneca LOSEC (omeprazole magnesium) prescribing information. AstraZeneca Canada Inc., Mississauga, Ontario www.pulsus.com/cddw2002/losecpi. htm. Accessed on 8 Sep 2006